Contemporary Treatment of Heart Failure

Abstract

Heart failure (HF) affects 2.4% of the adult population in the United States and is associated with high health care costs. Medical and device therapy delay disease progression and improve survival in HF with reduced ejection fraction. Stage D HF is characterized by significant functional limitation, frequent HF hospitalization for decompensation, intolerance of medical therapy, use of inotropes, and high diuretic requirement. Advanced therapies with left ventricular assist devices and cardiac transplantation reduce mortality and improve quality of life, and early referral to specialized centers is imperative for patient selection and success with these therapies.

Keywords: Advanced heart failure; Cardiac transplantation; Device therapy in heart failure; Heart failure with reduced ejection fraction (HFrEF); Mechanical circulatory support; Pharmacotherapy in heart failure; Stage D heart failure.